How Will the Market React to Perrigo Company PLC (PRGO) Stock Getting a Bullish Rating

Overall market sentiment has been high on Perrigo Company PLC (PRGO) stock lately. PRGO receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Perrigo Company PLC has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on PRGO!

See Full PRGO Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With PRGO Stock Today?

Perrigo Company PLC (PRGO) stock is trading at $30.35 as of 2:13 PM on Wednesday, Nov 22, a rise of $0.09, or 0.3% from the previous closing price of $30.26. Volume today is less active than usual. So far 1,100,982 shares have traded compared to average volume of 1,630,303 shares. The stock has traded between $30.26 and $31.02 so far today.

More About Perrigo Company PLC

Perrigo Co PLC is a leading private label supplier of generic over the counter (OTC) drugs in the U.S. and Europe. The company's product offerings fall under traditional OTC drug categories (i.e. cough, cold, allergy, pain), in addition to oral care, infant nutrition (formula), and nicotine cessation aids. In addition to private label manufacturing, the company also sells products under its own brands (largely in the skincare and oral-care category). The company became a pure-play in OTC consumer healthcare in 2021, following a series of divestitures over several years (sold off generic prescription topicals, animal health, and active pharmaceutical ingredient business). In late 2021, Perrigo signed an offer to acquire HRA Pharma. Click Here to get the full Stock Report for Perrigo Company PLC stock.